David W. Nassif Insider Trading $AXON Sio Gene Therapies Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David W. Nassif.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David W. Nassif. David W. Nassif is EVP and CFO in SteadyMed Ltd. ($STDY) and Chief Financial Officer in Sio Gene Therapies Inc. ($AXON) and Principal Financial Officer in Axovant Gene Therapies Ltd. ($AXON).
David W. Nassif in Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David W. Nassif: Chief Financial Officer, Principal Financial Officer
Holdings: 34,004 shares
Current Value: $441,032
Latest Transaction: Apr 19 2021
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David W. Nassif in Sio Gene Therapies Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Option Exercise | A | 2.47 | 239,000 | 590,330 | 239,000 | |
| Apr 19 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Option Exercise | A | 2.47 | 239,000 | 590,330 | 239,000 | |
| Mar 22 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Option Exercise | D | 0.00 | 15,060 | 0 | 0 | |
| Mar 22 2021 | AXON | Sio Gene Therapies ... | Nassif David W. | Chief Financial Off ... | Grant | A | 0.00 | 15,060 | 0 | 34,004 | 18.9 K to 34 K (+79.50 %) |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | D | 0.00 | 15,060 | 0 | 15,060 | |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Payment of Exercise | F | 3.25 | 5,266 | 17,115 | 18,944 | 24.2 K to 18.9 K (-21.75 %) |
| Jun 15 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Grant | A | 0.00 | 15,060 | 0 | 24,210 | 9.2 K to 24.2 K (+164.59 %) |
| Apr 17 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 0.00 | 52,600 | 0 | 52,600 | |
| Apr 17 2020 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 3.45 | 78,900 | 272,205 | 78,900 | |
| Sep 24 2019 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 0.00 | 30,120 | 0 | 30,120 | |
| Jul 02 2019 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 6.42 | 75,000 | 481,500 | 75,000 | |
| Jul 02 2019 | AXON | Axovant Gene Thera ... | Nassif David W. | Principal Financial ... | Option Exercise | A | 6.42 | 150,000 | 963,000 | 150,000 |
Page: 1